Structural MRI biomarkers for preclinical and mild Alzheimer's disease. - Test2 - elhamkhani - TriplyDB

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

http://www.wikidata.org/entity/Q34180987

about

One-year brain atrophy evident in healthy aging Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments The clinical value of large neuroimaging data sets in Alzheimer's disease The Alzheimer's disease neuroimaging initiative: progress report and future plans Dementia and neuroimaging.Brain development and aging: overlapping and unique patterns of change.Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.A comparison of FreeSurfer-generated data with and without manual intervention.Seed Location Impacts Whole-Brain Structural Network Comparisons between Healthy Elderly and Individuals with Alzheimer's Disease.A generative probability model of joint label fusion for multi-atlas based brain segmentation.Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.The Sub-Classification of Amnestic Mild Cognitive Impairment Using MRI-Based Cortical Thickness Measures.Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease.CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.Quantitative structural MRI for early detection of Alzheimer's disease.Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's disease Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data.New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline.The role of clusterin in amyloid-β-associated neurodegeneration.Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort Level of executive function influences verbal memory in amnestic mild cognitive impairment and predicts prefrontal and posterior cingulate thickness.An MRI-derived definition of MCI-to-AD conversion for long-term, automatic prognosis of MCI patients.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease.Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis.Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data.Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data.Abnormalities of cortical thickness, subcortical shapes, and white matter integrity in subcortical vascular cognitive impairment.Functional imaging of hippocampal dysfunction among persons with Alzheimer's disease: a proof-of-concept study.Novel ThickNet features for the discrimination of amnestic MCI subtypes.Enrichment and stratification for predementia Alzheimer disease clinical trials.Mild cognitive impairment, poor episodic memory, and late-life depression are associated with cerebral cortical thinning and increased white matter hyperintensities.

P2860

Q24642943-60599ABC-A7AE-46DB-B7AE-841AF9E376C7 Q26801629-D1294547-5FAA-4F75-8017-00592F6D5F57 Q27006831-68DA8019-9C9D-4145-9ADD-DC909FF46D10 Q27026362-6463C77A-D563-428A-A0E3-BA6A5B2BFDC4 Q28709465-9A9456E2-5452-4D03-94AB-5DB9DF1C5D93 Q28749585-26A167C4-715F-497D-AB9A-E5F62AA98FC5 Q30581757-B029726F-7AAC-40B6-8816-5311B795FE17 Q30843829-F8235F71-C342-468D-B34A-E410618A712E Q30930965-FA07128B-CE4B-4C7F-926A-2C5FEC5CB7DD Q30971403-E4E14B52-2872-4BBB-83A1-CA2113FA1EC9 Q30996799-F4C7E263-622C-4CD7-8459-987F5C34F52C Q31018228-4BE4120E-8661-4AE7-BEB0-41FDC5CC8D03 Q33607915-4DA53FAD-45EB-4606-979F-1D5E82D9A97E Q33624088-C31633F9-F62D-4963-8FC5-5BF7A015D8BB Q33651118-E3681427-9E24-43E9-A7FF-3306999E67F0 Q33659817-51EA119F-48B6-4843-9573-A2EA3B5C854A Q33663207-BAAC943A-6223-4423-BD6C-A1390915EDC5 Q33689474-5D64B7B3-40A2-4635-B864-3DB88B404341 Q33729033-A5400390-9973-4E03-A6BD-8A10C4E66DF9 Q33762662-718ED783-5158-4371-A365-F18F45F41D6D Q33776799-B9FB5ABA-D889-4007-BBB3-52EF7B95A82B Q33816135-E066452D-252A-4A68-8F67-5E8C1F837BDC Q33881726-DE609758-E347-4FC1-BC44-7A946CE1C783 Q33987715-B5619414-5A1B-40F3-B90F-20DDB9BD2E77 Q33988464-6CA9F571-51F8-45CC-9516-2AF6BCB0031E Q33996059-1473B431-ABA1-4D20-8BAB-27FD0BF66865 Q34030557-66DAD68F-90AD-4214-AEB3-60C0545B0785 Q34055510-DE92F3B0-2DCC-4593-BC47-BD7DAF4A2F7A Q34065449-352D133E-05EA-477B-B648-9E8C2BDC92E8 Q34073224-EB822DEC-36C9-49DE-A1B6-80C525C51045 Q34088600-6E44888E-41FE-4CA8-868E-58030EEFC6A5 Q34126757-34B92AC1-30EB-4997-AEA9-9A0DE48B1967 Q34176310-8110291D-B317-4BEC-8402-FAC6592DDF5C Q34231349-B7CA1B78-A1F9-4471-A68D-4A382BCB2B8C Q34316574-810584C2-A2AF-4B5A-BBFE-69E74B1B03F8 Q34357921-1CC565D6-CBF5-4752-BCCD-F48D7CAD65E2 Q34392882-A5903953-0775-4F62-9E1D-2E3D450AA750 Q34431841-8B164CD1-7376-4FAC-BA8C-BE11617A2F4F Q34452239-CFA96AFF-41C4-4D9C-9F43-647767EE8077 Q34471412-5E7B1AD1-E301-41B8-B2C7-7934582575E8

P2860

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

http://www.wikidata.org/entity/Q34180987

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

@ast

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

@en

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

@nl

type

label

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

@ast

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

@en

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

@nl

prefLabel

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

@ast

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

@en

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

@nl

P1433

Q34180987-44309914-9A2C-4D72-8173-C65D70D32618

P1476

Q34180987-16A97731-ED9D-409E-85E7-DBBCDDC5D191

P2093

Q34180987-03C2FCF3-E780-40E7-9C6C-693FF2399CA6

Q34180987-362BDA78-B85B-46D6-B1B7-90DDE9FAF57C

Q34180987-56F9759C-F10E-4406-BB59-0AF4F8AA337F

Q34180987-5F1119F1-806B-4620-9580-A18C44CD88E9

Q34180987-E7916E3D-A68B-441F-84C0-D13764BA264F

P2860

Q34180987-0C35A9F1-D19C-4916-B941-94445FF9FD4A

Q34180987-0E392BF7-B227-456E-AC26-D1BFE5E4F35A

Q34180987-11E08847-D228-41E3-B87A-B08FCD2C98DB

Q34180987-145C61FD-D9F1-45FF-9B51-E4EB1ECF0021

Q34180987-1494CE85-BB08-4AC8-A6DC-6B9935147411

Q34180987-1C8DFE55-87D4-4987-8A97-EBEB44E7245D

Q34180987-1E028F8A-263D-43B3-9628-C1A189A4A860

Q34180987-1E0D042D-9E66-4BFB-AB5E-D54B57ADDB07

Q34180987-2BED38D2-E899-4A2F-9691-331B20A893CE

Q34180987-2CBDDF2D-2C9E-4305-A6BF-F43A4E48AD8E

P304

Q34180987-95511590-E565-4D0E-89C0-C3A5313ABC8E

P31

Q34180987-58E6B2B0-588E-4A6A-A290-07FA230F180A

P356

Q34180987-8A06A2BD-1C6A-4688-8182-E0306A928B17

P433

Q34180987-2F74200F-B43B-4E8D-8730-35676E5F4EB1

P478

Q34180987-003769A4-3B6C-4B68-80E2-5B02E853C181

P50

Q34180987-367D1C42-FDFB-4B5C-9445-DCF5181AE115

Q34180987-8523472E-F776-4125-954D-A17E572424B4

Q34180987-DB12B025-47EA-4C60-8EDB-A50631D2729E

P577

Q34180987-42CCA895-D05E-471A-87A2-F36D32828631

P5875

Q34180987-842B3BDB-352F-4C56-BFCB-0BC284089F1B

P698

Q34180987-345BA1EC-8BF7-4133-9D88-15F2AFD4B6C3

P921

Q34180987-40F11BB2-1FD1-4309-B80B-77CF36568402

Q34180987-A63B59F5-A31F-4115-933E-03B4AE0F87F7

P932

Q34180987-1CBD1CD5-84CA-4739-8915-379EBEF39A3F

P356

P1433

Human Brain Mapping

P1476

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

@en

P2093

Adam S Fleisher

http://www.w3.org/2001/XMLSchema#string

David S Karow

http://www.w3.org/2001/XMLSchema#string

Donald J Hagler

http://www.w3.org/2001/XMLSchema#string

Elaine H Wu

http://www.w3.org/2001/XMLSchema#string

Linda K McEvoy

http://www.w3.org/2001/XMLSchema#string

P2860

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

“Mini-mental state”

Neuropathological stageing of Alzheimer-related changes

Cortical Surface-Based Analysis

Neuropathologic features of amnestic mild cognitive impairment

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system

P304

3238-3253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HBM.20744

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Christine Fennema-Notestine

Alzheimer's Disease Neuroimaging Initiative

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24193072

http://www.w3.org/2001/XMLSchema#string

P698

19277975

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2951116

http://www.w3.org/2001/XMLSchema#string